Penny Gilbert

Ranked in 2 Practice Areas

Band 1

Intellectual Property: Patent Litigation

London (Firms)

18 Years Ranked

Band 1

Life Sciences: IP/Patent Litigation

UK-wide

15 Years Ranked

Ranked in Guides

Global 2025

About

Provided by Penny Gilbert

Practice Areas

Penny specialises in litigation and advisory work relating to intellectual property rights particularly in the pharmaceutical and biotechnology fields. Her background in the life sciences has led to her acting in patent litigation for clients ranging from pharmaceutical multinationals to early stage biotech companies. She has also acted in litigation and arbitrations over disputed technology contracts, including patent licences. She is experienced in co-ordinating multi-jurisdictional litigation, has represented clients in EPO opposition proceedings and in referrals to the CJEU and EFTA Court on the SPC Regulation. She also advises on freedom-to-operate issues. Penny is a solicitor advocate (admitted in England and Ireland), a UPC representative and a qualified mediator.

Career

Brasenose College, Oxford (1982 MA Biochemistry, 1986 DPhil Molecular Biology); Bristol University (Diploma in IP Law); Solicitor (England & Wales) 1991; Partner, Bristows 1998-2007; Partner, Powell Gilbert LLP 2007; Solicitor (Ireland) 2016; UPC Representative 2023.

Professional Memberships

Past president and advisory board member of EPLAW; Member of AIPPI; LSLA; IPLA; LES.

Chambers Review

Provided by Chambers

UK

Intellectual Property: Patent Litigation - London (Firms)

Band 1

Individual Editorial

Penny Gilbert is one of the most accomplished patent litigators in Europe, specialising in pharmaceuticals and biotechnology. She has deep expertise across a magisterial sweep of technologies, not least vaccines, medical devices and antibody drugs.

Learn more about this team❖View ranking table

Life Sciences: IP/Patent Litigation - UK-wide

Band 1

Individual Editorial

Penny Gilbert is celebrated for her magisterial handling of patent infringement and revocation cases for clients spanning emergent biotechnology companies and global pharmaceutical corporations.

Learn more about this team❖View ranking table